Trial Profile
Phase 1-2a dose-ranging study of TLK286 [canfosfamide] in combination with cisplatin as first-line therapy in locally advanced or metastatic non-small cell lung cancer
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 27 Jul 2011
Price :
$35
*
At a glance
- Drugs Canfosfamide (Primary) ; Cisplatin
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 29 Sep 2005 New trial record.